Donanemab in Early Alzheimer’s Disease
In patients with early Alzheimer's disease, donanemab resulted in a better composite score for cognition and for the ability to perform activities of daily living than placebo a...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,451
- Institution
- Eli Lilly (Singapore)
External Links
Identifiers
- ORCID
- 0000-0002-6508-1361
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.